Home Infusion Therapy Market size to exceed $81.5bn by 2032

Home Infusion Therapy Market size is anticipated to surpass USD 81.5 billion by 2032, as per a new research report announced by Global Market Insights Inc.
 

A substantial rise in the number of patients suffering from chronic ailments has fueled the need for home infusion therapy devices. Chronic diseases such as cancer, ulcerative colitis, asthma, chronic obstructive pulmonary disease (COPD), Alzheimer’s, arthritis, and Crohn’s disease can significantly impact a patient’s quality of life. A growing patient pool worldwide indicates lucrative demand for home infusion therapy services over the coming years.
 

However, the lack of reimbursement policies is likely to be a key factor restraining industry progress. Infusion therapy for home care has gained popularity among long-term care facilities and local hospitals. Despite this, several private insurers and insurance firms have reduced reimbursement rates on infusion therapy administered at home care settings. Medicare has given intravenous immunoglobulin a Tier IV status, thus compelling patients to pay 10% to 30% of co-insurance for the therapy.
 

Rise in cases of CVD will fuel the demand for needleless connectors

Home infusion therapy market from the needleless connectors segment will surpass USD 25 billion by 2032. Needleless connectors (NCs) are vital instruments used to connect to the end of vascular catheters and provide access for infusion and aspiration. These devices are commonly used in homecare settings for the diagnosis and treatment of cardiovascular diseases (CVD). Rising incidences of CVDs due to sedentary lifestyles will propel the demand for needless connectors in home infusion therapy.
 

Browse key industry insights spread across 144 pages with 121 market data tables & 14 figures & charts from the report, “Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/home-infusion-therapy-market-report
 

Lack of nutrition due to diverse health conditions to drive the need for home enteral nutrition therapy

Home infusion therapy market from the enteral nutrition application is projected to expand at over 11% CAGR between 2023-2032. Enteral nutrition offers an effective alternative to long-term oral feeding through the gastrointestinal tract. Patients that face issues like difficulty in swallowing food, decreased appetite, nutritional deficiency, or post-surgery complications require home enteral nutrition therapy. Multiple health conditions such as trauma to the digestive tract, certain types of cancers, and amyotrophic lateral sclerosis (ALS) rely on home enteral nutrition (HEN).
 

Awareness regarding the benefits of home infusion therapy in Europe

Europe home infusion therapy market is anticipated to reach USD 24.9 billion by 2032. The high rate of hospitalization in the region due to the rising prevalence of diabetes and cancer will complement industry growth. The European Union reported nearly 4 million new cancer cases in 2021 and estimates a consistent rise over the coming years. Countries across the region have deployed favorable healthcare policies along with initiatives to raise awareness regarding the benefits of homecare facilities. Regulatory authorities are focusing on enhancing overall healthcare capabilities and providing improved patient care, which will positively affect the regional industry dynamics.
 

New mergers & acquisitions among home infusion therapy providers

B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius Kabi, ICU Medical Inc., Terumo Corporation, Moog Inc., Halyard Health, Inc. (Avanos Medical), Amsino International, Inc., Lepu Medical Technology, and JMS Co. Ltd. are some of the key players in the global market. These companies are focusing on strategic alliances to gain a competitive lead over other related firms.